Drug Shortage Report for TARO-CARBAMAZEPINE
| Report ID | 215076 |
| Drug Identification Number | 02367394 |
| Brand name | TARO-CARBAMAZEPINE |
| Common or Proper name | CARBAMAZEPINE |
| Company Name | TARO PHARMACEUTICALS INC |
| Market Status | MARKETED |
| Active Ingredient(s) | CARBAMAZEPINE |
| Strength(s) | 100MG |
| Dosage form(s) | SUSPENSION |
| Route of administration | ORAL ORAL |
| Packaging size | 450 |
| ATC code | N03AF |
| ATC description | ANTIEPILEPTICS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2023-08-03 |
| Estimated end date | 2024-01-19 |
| Actual end date | 2024-01-09 |
| Shortage status | Resolved |
| Updated date | 2024-02-08 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 130 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2024-02-08 | French | Compare |
| v3 | 2024-02-08 | English | Compare |
| v2 | 2024-01-05 | French | Compare |
| v1 | 2024-01-05 | English | Compare |
Showing 1 to 4 of 4